| |
| |
|
| Insider
Information: |
Shafer Bradford J |
| Relationship: |
EVP, Gen. Counsel, Sec... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
720,844 |
|
|
Indirect Shares
|
8,250 |
|
|
| Direct
Value |
$9,834,001 |
|
|
|
Indirect Value
|
$133,568 |
|
|
| Total
Shares |
729,094 |
|
|
| Total
Value |
$9,967,569 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Innoviva Inc |
INVA |
Sr VP, Gen. Counsel, S... |
2014-08-20 |
443,013 |
2014-08-12 |
8,250 |
Premium* |
|
|
Theravance Biopharma, Inc. |
TBPH |
EVP, Gen. Counsel, Sec... |
2021-08-20 |
277,831 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2014-03-03 |
4 |
AS |
$36.72 |
$2,417,314 |
D/D |
(65,806) |
326,731 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2013-06-07 |
4 |
S |
$35.04 |
$1,087,572 |
D/D |
(31,038) |
303,416 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2016-08-22 |
4 |
S |
$27.16 |
$1,007,038 |
D/D |
(37,078) |
195,730 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2014-03-03 |
4 |
OE |
$9.69 |
$937,488 |
D/D |
96,773 |
392,537 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2017-03-03 |
4 |
S |
$31.86 |
$854,772 |
D/D |
(26,829) |
161,453 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2020-02-20 |
4 |
D |
$25.90 |
$761,512 |
D/D |
(29,402) |
264,932 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2018-08-08 |
4 |
S |
$27.85 |
$706,182 |
D/D |
(25,355) |
98,124 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2007-10-31 |
4 |
S |
$25.00 |
$625,000 |
D/D |
(25,000) |
222,568 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2014-05-09 |
4 |
D |
$26.86 |
$613,294 |
D/D |
(22,833) |
341,398 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2014-08-11 |
4 |
S |
$22.12 |
$599,629 |
D/D |
(27,108) |
447,322 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2021-02-20 |
4 |
D |
$18.79 |
$598,819 |
D/D |
(31,869) |
285,047 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2008-07-30 |
4 |
S |
$15.97 |
$553,689 |
D/D |
(34,676) |
193,268 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2018-05-20 |
4 |
D |
$24.31 |
$530,250 |
D/D |
(21,812) |
143,464 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2014-08-11 |
4 |
OE |
$14.53 |
$489,182 |
D/D |
33,667 |
474,430 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2011-03-11 |
4 |
S |
$22.76 |
$460,617 |
D/D |
(20,238) |
346,825 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2017-09-06 |
4 |
S |
$30.77 |
$451,350 |
D/D |
(14,670) |
134,327 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2017-02-20 |
4 |
D |
$33.78 |
$420,223 |
D/D |
(12,440) |
188,282 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2011-11-28 |
4 |
AS |
$21.00 |
$420,000 |
D/D |
(20,000) |
350,673 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2007-08-01 |
4 |
S |
$25.73 |
$419,431 |
D/D |
(16,200) |
248,235 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Sr VP, Gen. Counsel, Secretary |
• – – |
2016-02-20 |
4 |
D |
$15.65 |
$296,098 |
D/D |
(18,920) |
136,165 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2017-05-20 |
4 |
D |
$36.83 |
$260,720 |
D/D |
(7,079) |
156,076 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2011-11-28 |
4 |
OE |
$8.53 |
$257,649 |
D/D |
30,205 |
370,673 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2018-06-06 |
4 |
S |
$24.09 |
$244,268 |
D/D |
(10,140) |
133,324 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2016-08-18 |
4 |
S |
$28.55 |
$204,818 |
D/D |
(7,174) |
241,686 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2017-11-20 |
4 |
D |
$28.58 |
$202,318 |
D/D |
(7,079) |
127,248 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
